We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

151 hedge funds and large institutions have $916M invested in Exact Sciences in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 12

64% more call options, than puts

Call options by funds: $67.8M | Put options by funds: $41.3M

22% more capital invested

Capital invested by funds: $752M → $916M (+$164M)

15% more funds holding

Funds holding: 131151 (+20)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 51

Holders
151
Holders Change
+20
Holders Change %
+15.27%
% of All Funds
4.36%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
32
Increased
49
Reduced
51
Closed
12
Calls
$67.8M
Puts
$41.3M
Net Calls
+$26.5M
Net Calls Change
+$31.6M
Name Holding Trade Value Shares
Change
Change in
Stake
GPGA
101
Grandeur Peak Global Advisors
Utah
$392K +$253K +18,700 +209%
VKH
102
Virtu KCG Holdings
New York
$389K +$203K +15,035 +121%
WCM
103
Washington Capital Management
Washington
$364K -$1.91M -141,333 -85%
GT
104
Glenmede Trust
Pennsylvania
$350K
SWM
105
SVA Wealth Management
Wisconsin
$325K +$80.6K +5,965 +35%
US Bancorp
106
US Bancorp
Minnesota
$298K -$244K -18,065 -46%
PP
107
PDT Partners
New York
$284K +$271K +20,064 New
COPPSERS
108
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$275K +$262K +19,400 New
Marshall Wace
109
Marshall Wace
United Kingdom
$275K +$262K +19,433 New
NIM
110
Needham Investment Management
New York
$262K +$250K +18,500 New
LCP
111
Legacy Capital Partners
Wisconsin
$241K
RJA
112
Raymond James & Associates
Florida
$237K -$10.8K -800 -5%
PSC
113
Piper Sandler & Co
Minnesota
$213K +$203K +15,000 New
DC
114
Deere & Company
Illinois
$199K +$189K +14,010 New
WAM
115
Wolverine Asset Management
Illinois
$194K -$72.9K -5,400 -28%
Two Sigma Investments
116
Two Sigma Investments
New York
$191K +$24.1K +1,787 +15%
LPL Financial
117
LPL Financial
California
$188K +$16K +1,185 +10%
TG
118
TCW Group
California
$173K
Bessemer Group
119
Bessemer Group
New Jersey
$171K
SB
120
Suntrust Banks
Georgia
$169K +$162K +11,999 New
JWM
121
Jacobus Wealth Management
Wisconsin
$166K
Citigroup
122
Citigroup
New York
$162K -$169K -12,511 -52%
Tudor Investment Corp
123
Tudor Investment Corp
Connecticut
$156K +$149K +11,040 New
Jane Street
124
Jane Street
New York
$145K -$206K -15,237 -60%
Nomura Holdings
125
Nomura Holdings
Japan
$144K -$330K -24,414 -71%

EXAS Hedge Fund Activity: Q1 2014 in Review

151 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2014, worth a combined $916M — up 22% from $752M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new EXAS positions and 12 closed out — a net gain of 20 holders — while 49 added to existing stakes and 51 trimmed.

The largest buyer was Invesco, adding an estimated $26.7M. The largest seller was OrbiMed, cutting an estimated $41.8M.

  • 151 institutional investors held Exact Sciences (EXAS) as of Q1 2014, up from 131 in Q4 2013.
  • Funds reported $916M of Exact Sciences stock for Q1 2014, up 22% quarter-over-quarter.
  • 32 funds opened new Exact Sciences positions in Q1 2014 and 12 closed out, a net change of +20 holders.
  • The largest Exact Sciences buyer in Q1 2014 was Invesco, an estimated $26.7M added.
  • The largest Exact Sciences seller in Q1 2014 was OrbiMed, an estimated $41.8M sold.

Based on aggregated 13F filings for Q1 2014.